Stimulation Therapy versus Artificial Tears for the Treatment of Post-LASIK (laser in situ keratomileusis) Dry Eye
Neurostimulation versus Artificial Tears to Treat Post-LASIK Dry Eye in Adults Measured via Two Dry Eye Questionnaires
Oculeve, Inc.
60 participants
May 30, 2014
Interventional
Conditions
Summary
The purpose of this study is to evaluate dry eye symptoms and signs in patients having laser in situ keratomileusis (LASIK) randomized to receive either stimulation therapy or unpreserved artificial tears pre- and post-LASIK.
Eligibility
Inclusion Criteria4
- Patients meeting all criteria for appropriateness of LASIK surgery instituted by the treating centre with an established date for bilateral primary LASIK surgery
- Willing to sign the informed consent and deemed capable of complying with the requirements of the study protocol
- Normal lid anatomy, blinking function and closure
- Corrected visual acuity of 20/25 (Snellen equivalent) or better in each eye
Exclusion Criteria10
- Cardiac demand pacemaker, implanted defibrillator, or other active implanted metallic or electronic device
- Diagnosed epilepsy with seizures within the past five years
- Coagulation disorders such as haemophilia and thrombocytopenia
- Active or uncontrolled severe systemic allergy, chronic seasonal allergies, rhinitis or sinusitis requiring treatment or active/untreated nasal infection at the time of the baseline examination
- Punctal plugs
- Contact lens wear during the study
- Lacrimal, nasal or sinus neoplasia, significant trauma, or invasive surgery
- Chronic or recurrent epistaxis, history of cocaine abuse, or Wegener’s granulomatosis
- Participation in any clinical trial with a new active substance or a new device during the past three months
- Women who are pregnant, planning a pregnancy or nursing at study entry
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Arm 1 – Neurostimulation device (EMS 2000) - Lacrimal gland neurostimulation is self-administered nasally during waking hours. The current provided is approximately 1 milliamp with the patient controlling the amplitude with a knob. The recommended duration of treatment is approximately 30 seconds and the recommended treatment frequency is every two to four hours. The duration of the intervention period is three months. The allocated treatment will commence two days prior to LASIK and continue post-LASIK. Adherence to the intervention will be monitored by questioning of participants by study staff with responses recorded on case report forms. Arm 2 – One drop of unpreserved artificial tears per eye to be self-administered during waking hours every two to four hours or as needed for a period of three months. The allocated treatment will commence two days prior to LASIK and continue post-LASIK. Patient reports of their use of artificial tears are recorded on case report forms to monitor adherence to the intervention.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12614000272695